hydrogen sulfide has been researched along with Intraocular Pressure in 7 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glaucoma is an optic neuropathy disorder marked by progressive degeneration of the retinal ganglion cells (RGC)." | 6.82 | Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies. ( Mhatre, S; Opere, CA; Singh, S, 2022) |
| "Glaucoma is a neurodegenerative eye disease characterized by gradually impaired visual field and irreversible blindness due to retinal ganglion cell (RGC) loss." | 5.51 | Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma. ( Guo, L; Huang, P; Huang, S; Lin, Z; Liu, X; Shen, X; Yu, H; Zhong, Y, 2019) |
| "Glaucoma is an irreversible and blinding neurodegenerative disease of the eye, and is characterized by progressive loss of retinal ganglion cells (RGCs)." | 5.46 | Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. ( Guo, L; Huang, P; Huang, S; Leung, CK; Lin, Z; Liu, X; Wang, J; Xu, S; Zhong, Y, 2017) |
| "A hydrogen sulphide-releasing derivative of latanoprost acid (ACS 67) was synthesized and tested in vivo to evaluate its activity on reduction of intraocular pressure and tolerability." | 3.75 | New prostaglandin derivative for glaucoma treatment. ( Lanzi, C; Masini, E; Perrino, E; Soldato, PD; Sparatore, A; Uliva, C, 2009) |
| "Glaucoma is an optic neuropathy disorder marked by progressive degeneration of the retinal ganglion cells (RGC)." | 2.82 | Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies. ( Mhatre, S; Opere, CA; Singh, S, 2022) |
| "Glaucoma is a neurodegenerative eye disease characterized by gradually impaired visual field and irreversible blindness due to retinal ganglion cell (RGC) loss." | 1.51 | Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma. ( Guo, L; Huang, P; Huang, S; Lin, Z; Liu, X; Shen, X; Yu, H; Zhong, Y, 2019) |
| "Glaucoma is an irreversible and blinding neurodegenerative disease of the eye, and is characterized by progressive loss of retinal ganglion cells (RGCs)." | 1.46 | Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. ( Guo, L; Huang, P; Huang, S; Leung, CK; Lin, Z; Liu, X; Wang, J; Xu, S; Zhong, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Mhatre, S | 1 |
| Opere, CA | 1 |
| Singh, S | 1 |
| Huang, S | 2 |
| Huang, P | 2 |
| Yu, H | 1 |
| Lin, Z | 2 |
| Liu, X | 2 |
| Shen, X | 1 |
| Guo, L | 2 |
| Zhong, Y | 2 |
| Liu, H | 1 |
| Anders, F | 1 |
| Thanos, S | 1 |
| Mann, C | 1 |
| Liu, A | 1 |
| Grus, FH | 1 |
| Pfeiffer, N | 1 |
| Prokosch-Willing, V | 1 |
| Han, Y | 1 |
| Shang, Q | 1 |
| Yao, J | 1 |
| Ji, Y | 1 |
| Wang, J | 1 |
| Xu, S | 1 |
| Leung, CK | 1 |
| Perrino, E | 1 |
| Uliva, C | 1 |
| Lanzi, C | 1 |
| Soldato, PD | 1 |
| Masini, E | 1 |
| Sparatore, A | 1 |
| Bucolo, C | 1 |
| Drago, F | 1 |
3 reviews available for hydrogen sulfide and Intraocular Pressure
| Article | Year |
|---|---|
Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies.
Topics: Animals; Aqueous Humor; Glaucoma; Hydrogen Sulfide; Intraocular Pressure; Mammals; Retinal Ganglion | 2022 |
Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases.
Topics: Animals; Blood-Retinal Barrier; Cyclic AMP; Diabetic Retinopathy; Glaucoma; Glycation End Products, | 2019 |
Carbon monoxide and the eye: Implications for glaucoma therapy.
Topics: Animals; Carbon Monoxide; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclini | 2011 |
4 other studies available for hydrogen sulfide and Intraocular Pressure
| Article | Year |
|---|---|
Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma.
Topics: Animals; Autophagy; Blotting, Western; Cell Survival; Flavonoids; Glaucoma; Hydrogen Sulfide; In Sit | 2019 |
Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Topics: Animals; Disease Models, Animal; Female; Glaucoma; Hydrogen Peroxide; Hydrogen Sulfide; Hydrostatic | 2017 |
Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model.
Topics: Animals; Cell Survival; Cells, Cultured; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Dis | 2017 |
New prostaglandin derivative for glaucoma treatment.
Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Eye Diseases; Glaucoma; Glutathione; Hydrogen Sulfi | 2009 |